Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Our goal is to study pharmacogenetics in Mexican-Americans, using depression treatments as a
proof of the concept that pharmacogenetic approaches can be used to optimize treatment
strategies for common and complex disorders in this population.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of General Medical Sciences (NIGMS)